Literature DB >> 17222523

Lipid vesicles for skin delivery of drugs: reviewing three decades of research.

Mustafa M A Elsayed1, Ossama Y Abdallah, Viviane F Naggar, Nawal M Khalafallah.   

Abstract

Since liposomes were first shown to be of potential value for topical therapy by Mezei and Gulasekharam in 1980, studies continued towards further investigation and development of lipid vesicles as carriers for skin delivery of drugs. Despite this long history of intensive research, lipid vesicles are still considered as a controversial class of dermal and transdermal carriers. Accordingly, this article provides an overview of the development of lipid vesicles for skin delivery of drugs, with special emphasis on recent advances in this field, including the development of deformable liposomes and ethosomes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17222523     DOI: 10.1016/j.ijpharm.2006.12.005

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  60 in total

1.  Topical delivery of hyaluronic acid into skin using SPACE-peptide carriers.

Authors:  Ming Chen; Vivek Gupta; Aaron C Anselmo; John A Muraski; Samir Mitragotri
Journal:  J Control Release       Date:  2013-10-12       Impact factor: 9.776

2.  Machine learning study for the prediction of transdermal peptide.

Authors:  Eunkyoung Jung; Seung-Hoon Choi; Nam Kyung Lee; Sang-Kee Kang; Yun-Jaie Choi; Jae-Min Shin; Kihang Choi; Dong Hyun Jung
Journal:  J Comput Aided Mol Des       Date:  2011-03-30       Impact factor: 3.686

3.  Evaluation of propylene glycol nanoliposomes containing curcumin on burn wound model in rat: biocompatibility, wound healing, and anti-bacterial effects.

Authors:  Nooshin Kianvash; Abbas Bahador; Maryam Pourhajibagher; Homanaz Ghafari; Vahid Nikoui; Sayed Mehdi Rezayat; Ahmad Reza Dehpour; Alireza Partoazar
Journal:  Drug Deliv Transl Res       Date:  2017-10       Impact factor: 4.617

4.  Development of nanovesicular systems for dermal imiquimod delivery: physicochemical characterization and in vitro/in vivo evaluation.

Authors:  Man Ma; Jinping Wang; Fang Guo; Mingzhu Lei; Fengping Tan; Nan Li
Journal:  J Mater Sci Mater Med       Date:  2015-05-20       Impact factor: 3.896

5.  A combination therapy of nanoethosomal piroxicam formulation along with iontophoresis as an anti-inflammatory transdermal delivery system for wound healing.

Authors:  Mostafa Kazemi; Reza Mombeiny; Shima Tavakol; Peyman Keyhanvar; Kazem Mousavizadeh
Journal:  Int Wound J       Date:  2019-08-08       Impact factor: 3.315

6.  Non-invasive Oil-Based Method to Increase Topical Delivery of Nucleic Acids to Skin.

Authors:  Manika Vij; Shamshad Alam; Nidhi Gupta; Vishvabandhu Gotherwal; Hemlata Gautam; Kausar M Ansari; Deenan Santhiya; Vivek T Natarajan; Munia Ganguli
Journal:  Mol Ther       Date:  2017-03-30       Impact factor: 11.454

7.  Use of Nanoparticles in Delivery of Nucleic Acids for Melanoma Treatment.

Authors:  Mohammad A Obeid; Alaa A A Aljabali; Meriem Rezigue; Haneen Amawi; Hanin Alyamani; Shatha N Abdeljaber; Valerie A Ferro
Journal:  Methods Mol Biol       Date:  2021

8.  Aggregated Nanotransfersomal Dry Powder Inhalation of Itraconazole for Pulmonary Drug Delivery.

Authors:  Mehdi Hassanpour Aghdam; Saeed Ghanbarzadeh; Yousef Javadzadeh; Hamed Hamishehkar
Journal:  Adv Pharm Bull       Date:  2016-03-17

9.  Nanosized ethosomes bearing ketoprofen for improved transdermal delivery.

Authors:  Manish K Chourasia; Lifeng Kang; Sui Yung Chan
Journal:  Results Pharma Sci       Date:  2011-10-13

10.  Utility of nanosized microemulsion for transdermal delivery of tolterodine tartrate: ex-vivo permeation and in-vivo pharmacokinetic studies.

Authors:  Ahmed H Elshafeey; Amany O Kamel; Mohsen M Fathallah
Journal:  Pharm Res       Date:  2009-08-21       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.